Benzinga | Jun 28, 2021 07:30AM EDT

Raymond James Maintains Outperform on Veracyte, Raises Price Target to $50

Raymond James analyst Andrew Cooper maintains Veracyte (NASDAQ:VCYT) with a Outperform and raises the price target from $45 to $50.